| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1997) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | ZIF514RVZR |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| SEQUESTERING AGENT | Bilirubin sequestering agent | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Edema | 3 | D004487 | ClinicalTrials |
| Abortion, Habitual | 3 | D000026 | ClinicalTrials |
| Hypotension, Orthostatic | 3 | D007024 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 3 | D020277 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
| Shock, Septic | 3 | D012772 | ClinicalTrials |
| Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
| Sepsis | 3 | D018805 | ClinicalTrials |
| Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
| Ascites | 3 | D001201 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Adrenoleukodystrophy | 2 | D000326 | ClinicalTrials |
| alpha 1-Antitrypsin Deficiency | 2 | D019896 | ClinicalTrials |
| Craniocerebral Trauma | 2 | D006259 | ClinicalTrials |
| Macular Degeneration | 2 | D008268 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Scleroderma, Systemic | 2 | D012595 | ClinicalTrials |
| Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
| Inflammation | 2 | D007249 | ClinicalTrials |
| Shock | 2 | D012769 | ClinicalTrials |
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Pneumonia | 2 | D011014 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Cerebral Infarction | 2 | D002544 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Subarachnoid Hemorrhage | 1 | D013345 | ClinicalTrials |
Side Effects from Label
Side Effects (PT)
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 9048-46-8 |
| ChEMBL | CHEMBL1201451 |
| FDA SRS | ZIF514RVZR |
CONTENTS